At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of patients. Today, Pfizer Oncology has an industry-leading portfolio of innovative cancer medicines and biosimilars across more than 20 indications, including breast, prostate, kidney, lung and hematology.
